Legend Biotech Corp (LEGN)

Every figure this model derived for LEGN, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 28,600,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 901,900,000 CashAndCashEquivalents 2025-12-31
current assets 1,247,100,000 CurrentAssets 2025-12-31
current liabilities 636,400,000 CurrentLiabilities 2025-12-31
equity 1,002,100,000 Equity 2025-12-31
interest expense 21,400,000 FinanceCosts 2025-12-31
ocf -100,200,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 1,028,818,000 RevenueFromContractsWithCustomers 2025-12-31
sbc 64,600,000 ExpenseFromSharebasedPaymentTransactionsWithEmployees 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up LEGN on one particular measure came for.

RatioValue
cash operating margin-6.07
current ratio1.96
current ratio reported1.96
dilution pct0.8
fcf margin-12.52
growth cv1.46
interest cover-6.38
operating margin-13.27
owner earnings margin-18.8
revenue growth64.01
revenue growth per share62.7
roic-25.72
rule of 4050.74
sbc pct revenue6.28

What to be careful about

What this model itself distrusts about LEGN's figures. Written by the derivation as it ran, not added afterwards.